Skip to content

Comparisons between Major Hepatectomy and Partial Hepatectomy with or without Radiofrequency Ablation in the Treatment of Colorectal Cancer Liver Metastase

Comparisons between Major Hepatectomy and Partial Hepatectomy with or without Radiofrequency Ablation in the Treatment of Colorectal Cancer Liver Metastase

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500103045
Enrollment
Unknown
Registered
2025-05-23
Start date
2025-07-01
Completion date
Unknown
Last updated
2025-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver metastases from colorectal cancer

Interventions

The group of extensive hepatectomy:None
The group of partial hepatectomy:None

Sponsors

The First Affiliated Hospital of Xi'an Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1) The age of the patient is 18-85 years old; 2) Strictly meets the clinical diagnostic criteria for colorectal cancer liver metastasis or is confirmed by pathological histology or cytology and meets the indications for CRLM surgical resection; 3) After CRLM surgical resection; 4) Classification of liver function of Child-Pugh A or B. 5) Have not received prior systemic therapy or surgical treatment for liver cancer;

Exclusion criteria

Exclusion criteria: 1) Primary malignancy with or now diagnosed as non-colorectal in medical history; 2) Involvement of adjacent organs of the portal venous system or cancer embolism; 3) No regular physical examination, laboratory examination or imaging examination (abdominal CT) during the follow-up period; 4) Unable to extract enough data. 5) Pregnant or lactating women; 6) Presence of autoimmune diseases;

Design outcomes

Primary

MeasureTime frame
Overall survival;

Secondary

MeasureTime frame
Progression-free survival;Number of cases and incidence of serious adverse events;Number and rate of adverse events;

Countries

China

Contacts

Public ContactXin Zheng

The First Affiliated Hospital of Xi'an Jiaotong University

zhengxin@xjtufh.edu.cn+86 29 85323215

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026